NCT00156793View on ClinicalTrials.gov

Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

March 31, 2006

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

AI-700 contrast-enhanced echocardiography

Trial Locations (1)

02472

Acusphere, Inc., Watertown

Sponsors

Lead Sponsor

Acusphere
All Listed Sponsors
lead

Acusphere

INDUSTRY

NCT00156793 - Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging | Biotech Hunter | Biotech Hunter